FDA
approval
· 2021-12-10
FDA Approved: GALAFOLD — Supplemental Application (Amicus Therapeutics US, LLC)
Summary
The FDA approved a supplemental application for GALAFOLD (migalastat hydrochloride) to expand its labeling for Fabry disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GALAFOLD (MIGALASTAT HYDROCHLORIDE)